Another population‐based study from the NHANES III cohort confirmed the lack of impact of the PNPLA3 G variant on extrahepatic cancer‐related mortality in the entire cohort of 4814 subjects and in the subgroup of 1952 with steatosis [91]. This evidence concerns the gene PNPLA3 and steatosis.